Study of Rondecabtagene Autoleucel in Aggressive Large B-Cell Lymphoma
Lyell Immunopharma, Inc.
Lyell Immunopharma, Inc.
AIDS Malignancy Consortium
AvenCell Therapeutics, Inc.
Fred Hutchinson Cancer Center
Allogene Therapeutics
Massachusetts General Hospital
Masonic Cancer Center, University of Minnesota
Malaghan Institute of Medical Research
Fred Hutchinson Cancer Center
Jonsson Comprehensive Cancer Center
Mayo Clinic
H. Lee Moffitt Cancer Center and Research Institute
SWOG Cancer Research Network
Massachusetts General Hospital
Masonic Cancer Center, University of Minnesota
University of California, San Francisco
Gilead Sciences
Sana Biotechnology
Case Comprehensive Cancer Center
Sana Biotechnology
University of Maryland, Baltimore
Adicet Therapeutics
Peking University Cancer Hospital & Institute
CARGO Therapeutics
Miltenyi Biomedicine GmbH
Synthekine
Vanderbilt-Ingram Cancer Center
Shanghai Ming Ju Biotechnology Co., Ltd.
M.D. Anderson Cancer Center
University Health Network, Toronto
University Hospital Heidelberg
Gilead Sciences
Fred Hutchinson Cancer Center
Gilead Sciences
University College, London
TCR2 Therapeutics
National Institutes of Health Clinical Center (CC)
Fred Hutchinson Cancer Center
Fred Hutchinson Cancer Center
M.D. Anderson Cancer Center
Curocell Inc.
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
Massachusetts General Hospital
The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School
The Second Affiliated Hospital of Henan University of Traditional Chinese Medicine
Massachusetts General Hospital
Hoffmann-La Roche